A form of genetic variation, called differential RNA splicing, may have a role
in tumor aggressiveness and drug resistance in African American men with prostate cancer.
Not exact matches
«Genes may cause
tumor aggressiveness, drug resistance
in African - American prostate cancer: Research found many targeted therapies for prostate cancer may not be effective against
tumors in African - American men.»
Adjusted relative risk ratios (RRR) and 95 % confidence intervals for the association between prostate cancer incidence and the scores of adherence to Western, Prudent, and Mediterranean dietary patterns
in MCC - Spain study by
tumor aggressiveness and extension.
«FDG PET shows
tumor DNA levels
in blood are linked to NSCLC
aggressiveness: Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer.»
These results suggest that cfDNA might better reflect
tumors» biological behavior and
aggressiveness than
tumor burden
in metastatic NSCLC.
Italian researches have demonstrated a better way of determining the
aggressiveness of
tumors in patients with advanced non-small cell lung cancer (NSCLC).
In a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body
In a study presented
in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body
in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free
tumor DNA circulating
in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body
in the bloodstream correlates with
tumor metabolism (linked to cancer
aggressiveness), not
tumor burden (amount of cancer
in the body
in the body).
In their study published in The Journal of Pathology, the team shows that tumor relapse occurs when the body, in effect, mobilizes itself in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
In their study published
in The Journal of Pathology, the team shows that tumor relapse occurs when the body, in effect, mobilizes itself in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
in The Journal of Pathology, the team shows that
tumor relapse occurs when the body,
in effect, mobilizes itself in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
in effect, mobilizes itself
in favor of the tumor, causing recurrence of the disease, increasing its aggressiveness and creating metastases or tumor sprea
in favor of the
tumor, causing recurrence of the disease, increasing its
aggressiveness and creating metastases or
tumor spread.
Until now, scientists have failed to establish a link between the properties of pancreatic cancer, such as its
aggressiveness, and changes, i.e. mutations,
in the
tumor's genome.
GLUD1 and SLC25A13 have pivotal roles
in nutritional stress and are associated with
tumor aggressiveness and poorer prognosis of colorectal cancer.
«For example, restoring the lost enzymes
in the two metabolic pathways might slow
tumor progression and reduce
aggressiveness by inactivating oncogenic kinases and activating immune responses,» says Chakravarti, who holds the Max Morehouse Chair
in Cancer Research.
Blood clots lead to both destruction of the healthy and
tumor tissue and hypoxia, a shortage of oxygen that drives more
aggressiveness in the
tumor.
Aberrant expression of TUBB3 has also been found
in various
tumors of non-neural origin and can be used as a biomarker for cancer
aggressiveness and a marker for the tendency to respond poorly to chemotherapy.
Costimulatory B7 - H1
in renal cell carcinoma patients: Indicator of
tumor aggressiveness and potential therapeutic target.
Identification of genes associated with local
aggressiveness and metastatic behavior
in soft tissue
tumors.
Important features of XMRV biology include (1) tropism for a variety of cell lines, including prostate cancer DU145 and LNCaP cells [27], [43], [48], and human neural cell types [57], (2) adaptations that promote growth
in prostate epithelium and human - derived prostate cancer cell lines including an androgen response element
in the promoter region [58] and downregulation of APOBEC3G [59], and (3) cellular effects with potential oncogenic properties including increased
tumor aggressiveness mediated by downregulation of p27 [60] and differential regulation of several microRNAs [61].
Reproductive disorders such as pyometra, mammary
tumors, testicular cancer, ovarian cancer, and prostate cancer are also reduced / prevented with neutering (reviewed
in [2]-RRB- although neutering has been associated with increased risk or
aggressiveness of prostatic cancer [3 — 5].
Just as human
tumors are staged according to
aggressiveness and degree of development (early, late, etc.), so are the
tumors found
in cats.
The grade is an important factor
in determining the rate of
aggressiveness of the
tumor.
Grade II
tumors are considered to be
in between I and III
in terms of invasiveness and
aggressiveness.